Impact of Graves’ Disease and Antithyroid Drug Therapy on Bone Mineral Density – Pathophysiological Mechanisms and Clinical Relevance

Impact of Graves’ Disease and Antithyroid Drug Therapy on Bone Mineral Density – Pathophysiological Mechanisms and Clinical Relevance

Graves’ disease is an autoimmune disease characterized by excessive thyroid hormone production. One of the consequences of that state can be a decrease in bone mineral density (BMD). Graves’ disease is often treated with antithyroid drugs (ATD) as first line therapy, which can lead to disease rem...

Full description

Bibliographic Details
Main Authors: Dunja Mudri, Tomislav Kizivat, Martina Smolić, Ivica Mihaljević, Robert Smolić, Nikola Raguž Lučić, Ines Bilić-Ćurčić
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2022-01-01
Series:Acta Clinica Croatica
Subjects:
Graves’ disease
Bone Mineral Density
Wnt Signaling Pathway
Sclerostin
Dickkopf 1
Online Access:https://hrcak.srce.hr/file/428520

Internet

https://hrcak.srce.hr/file/428520

Similar Items